| Overview |
| bsm-62841r-apc-Cy5.5-100ul |
| Phospho-PLB (Ser16) Recombinant Antibody, APC-Cy5.5 Conjugated |
| WB |
| Mouse |
| Human |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PLB around the phosphorylation site of S16 |
| Ser166 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5350 |
| P26678 |
| Cytoplasm, Cell membrane |
| Cardiac phospholamban; CMD1P; CMH18; PLB; Pln. |
| Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz